LUNG
Pulmonx Corp.
NASDAQ · Healthcare · Medical - Devices · US
$1.75
−1.69%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.77x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.92x
- Price / sales
- 0.86x
- Price / cash flow
- -2.46x
Enterprise value
- Enterprise value
- $75.5M
- EV / sales
- 0.86x
- EV / EBITDA
- -1.76x
- EV / EBIT
- -1.63x
- Market cap
- $75.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026